4Johnson E,Enden T,Noreng H J,et al.Survival and complications after insertion of sclf-expandable metal stents for malignant oesophageal stenosis.Scand J Gastroenterol,2006,41:252-256.
5Solt J,Heiner J.Esophageal and gastrointestinal application of traditional and metal prostheses.Orv Hetil,2003,144:657663.
二级参考文献38
1[3]Rohatgi P R,Swisher S G,Correa A M,et al.Histologie subtypes as determinants of outcome in esophageal carcino-ma patients with pathologic complete response after preop-erative chemoradiotherapy[J].Cancer,2006,106(3):552-558.
3Vikram B, Hilaris BS, Anderson L, et al. Permanent^125 Iodineimplants in head and neck cancer. Cancer, 1983,51:1310-1314.
4Martinez-Monge R, Nag S, Martin EW.^125 Iodine brachytherapy for colorectal adenocarcinoma recurrent in the pelvis and paraortics. Int J Radiot Oncol biol Phys, 1998,42:545-550.
5Zelefsky MJ, Wallner KE, Ling CC, et al. Comparison of the 5-year outcome and morbidity of three-dimensional conformal radiotherapy versus transperineal permanent ^125Iodine implantation for early-stage prostatic cancer. J Clin Oncol, 1999,17:517-522.
6Battermann JJ.^125Iodine implantation for localized prostate cancer, the Utrecht University experience. Radiother Oncol,2000,57:269-272.
7王奇璐.肿瘤内科治疗的疗效评定[M].北京:人民卫生出版社,1999.33-34.
8Evans S M,Koch C J.Prognostic significance of tumor oxygenation in humans[J].Cancer Lett,2003,195(1):1-16.
9Hockel M,Knoop C,Schlenger K,et al.Intratumoral pO2 predicts survival in advanced cancer of the uterine cervix[J].Radiother Oncol,1993,26(1):45-50.
10Hockel M,Schlenger K,Aral B,et al.Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix[J].Cancer Res,1996,56(19):4509-4515.
